Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Stauderman

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Opinion in Immunology|April 23, 2026
CRAC channels as targets for immunotherapyKenneth Stauderman, Sudarshan Hebbar, Stefan Feske
Pancreas|May 3, 2021
Auxora for the Treatment of Patients With Acute Pancreatitis and Accompanying Systemic Inflammatory Response Syndrome: Clinical Development of a Calcium Release-Activated Calcium Channel InhibitorCharles Bruen, Joseph Miller, John Wilburn, et al.
Critical Care (London, England)|August 16, 2020
Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trialJoseph Miller, Charles Bruen, Michael Schnaus, et al.
Critical Care (London, England)|April 9, 2022
Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia: a randomized-controlled clinical trialCharles Bruen, Mukhtar Al-Saadi, Edward A Michelson, et al.
Eclinicalmedicine|April 6, 2026
Zegocractin for acute pancreatitis with systemic inflammatory response syndrome: a randomized, controlled, dose-ranging, phase 2b trialRobert Sutton, Pramod K Garg, Joseph Miller, et al.
The Journal of Physiology|May 4, 2019
The Orai Ca<sup>2+</sup> channel inhibitor CM4620 targets both parenchymal and immune cells to reduce inflammation in experimental acute pancreatitisRichard T Waldron, Yafeng Chen, Hung Pham, et al.
Science Advances|October 7, 2022
Distinct roles of ORAI1 in T cell-mediated allergic airway inflammation and immunity to influenza A virus infectionYin-Hu Wang, Lucile Noyer, Sascha Kahlfuss, et al.
EMBO Molecular Medicine|August 3, 2022
Store-operated calcium entry controls innate and adaptive immune cell function in inflammatory bowel diseaseMarilena Letizia, Yin-Hu Wang, Ulrike Kaufmann, et al.
JCI Insight|November 10, 2025
Combination of Orai1 inhibitor CM5480 with specific therapy mitigates pulmonary hypertension and its cardiac dysfunctionAnaïs Saint-Martin Willer, Grégoire Ruffenach, Bastien Masson, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Opinion in Immunology|April 23, 2026
CRAC channels as targets for immunotherapyKenneth Stauderman, Sudarshan Hebbar, Stefan Feske
Pancreas|May 3, 2021
Auxora for the Treatment of Patients With Acute Pancreatitis and Accompanying Systemic Inflammatory Response Syndrome: Clinical Development of a Calcium Release-Activated Calcium Channel InhibitorCharles Bruen, Joseph Miller, John Wilburn, et al.
Critical Care (London, England)|August 16, 2020
Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trialJoseph Miller, Charles Bruen, Michael Schnaus, et al.
Critical Care (London, England)|April 9, 2022
Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia: a randomized-controlled clinical trialCharles Bruen, Mukhtar Al-Saadi, Edward A Michelson, et al.
Eclinicalmedicine|April 6, 2026
Zegocractin for acute pancreatitis with systemic inflammatory response syndrome: a randomized, controlled, dose-ranging, phase 2b trialRobert Sutton, Pramod K Garg, Joseph Miller, et al.
The Journal of Physiology|May 4, 2019
The Orai Ca<sup>2+</sup> channel inhibitor CM4620 targets both parenchymal and immune cells to reduce inflammation in experimental acute pancreatitisRichard T Waldron, Yafeng Chen, Hung Pham, et al.
Science Advances|October 7, 2022
Distinct roles of ORAI1 in T cell-mediated allergic airway inflammation and immunity to influenza A virus infectionYin-Hu Wang, Lucile Noyer, Sascha Kahlfuss, et al.
EMBO Molecular Medicine|August 3, 2022
Store-operated calcium entry controls innate and adaptive immune cell function in inflammatory bowel diseaseMarilena Letizia, Yin-Hu Wang, Ulrike Kaufmann, et al.
JCI Insight|November 10, 2025
Combination of Orai1 inhibitor CM5480 with specific therapy mitigates pulmonary hypertension and its cardiac dysfunctionAnaïs Saint-Martin Willer, Grégoire Ruffenach, Bastien Masson, et al.
Pageof 1